| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.5 |